Effects of intravenous urocortin on angiotensin-converting enzyme in rats

Vascular Pharmacology

Volumn 44, Issue 4, 2006, Pages 238-246

  Yang, Cui ^a   Xu, Yinyan ^a   Mendez, Tavis ^b   Wang, Fang ^a   Yang, Qin ^c   Li, Shengnan ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS AT EL PASO   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

ACE inhibitors; Blood pressure; Renin angiotensin system; Urocortin; Vasoconstriction dilation

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANGIOTENSIN II; ASTRESSIN; CAPTOPRIL; CORTICOTROPIN RELEASING FACTOR; DIPEPTIDYL CARBOXYPEPTIDASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; UROCORTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME INHIBITION; IMMUNOFLUORESCENCE TEST; IMMUNOREACTIVITY; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIUM;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; AORTA; CAPTOPRIL; CELLS, CULTURED; CORTICOTROPIN-RELEASING HORMONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; FLAVONOIDS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; INJECTIONS, INTRAVENOUS; LUNG; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PEPTIDE FRAGMENTS; PEPTIDYL-DIPEPTIDASE A; PROTEIN KINASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TIME FACTORS; VASODILATOR AGENTS;

EID: 33644799148     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2006.01.001     Document Type: Article

References (47)

1. A.M. Abdelrahman, and C.C. Pang Regional haemodynamic effects of urocortin in the anaesthetized rat Eur. J. Pharmacol. 466 2003 317 321
2. A.M. Abdelrahman, S. Lin Lim, and C.C. Pang Influence of urocortin and corticotropin releasing factor on venous tone in conscious rats Eur. J. Pharmacol. 510 2005 107 111
3. R.G. Asmar, B. Pannier, J.P. Santoni, S. Laurent, G.M. London, B.I. Levy, and M.E. Safar Reversion of cardiac hypertrophy and reduced arterial compliance after converting enzyme inhibition in essential hypertension Circulation 78 1988 941 950
4. V. Beldent, A. Michaud, L. Wei, M.T. Chauvet, and P. Corvol Proteolytic release of human angiotensin-converting enzyme: localization of the cleavage site J. Biol. Chem. 268 1993 26428 26434
5. K.H. Berecek, S.J. King, and J.N. Wu Angiotensin-converting enzyme and converting enzyme inhibitors M.K. Raizada M.I. Phillips C. Sumners Cellular and Molecular Biology of the Renin-Angiotensin System 1993 CRC Press Boca Raton, FL 183 220
6. K.E. Bernstein, and B.C. Berk The biology of angiotensin II receptors Am. J. Kidney Dis. 22 1993 745 754
7. B.K. Brar, A.K. Jonassen, A. Stephanou, G. Santilli, J. Railson, R.A. Knight, D.M. Yellon, and D.S. Latchman Urocortin protects against ischemic and reperfusion injury via a MAPK-dependent pathway J. Biol. Chem. 275 2000 8508 8514
8. P.R. Caldwell, B.C. Seegal, K.C. Hsu, M. Das, and R.L. Soffer Angiotensin-converting enzyme: vascular endothelial localization Science 191 1976 1050 1051
9. K. Chen, X. Zhang, E.W. Dunham, and B.G. Zimmerman Kinin-mediated antihypertensive effect of captopril in deoxycorticosterone acetate-salt hypertension Hypertension 27 1996 85 89
10. Z.W. Chen, Y. Huang, Q. Yang, X. Li, W. Wei, and G.W. He Urocortin-induced relaxation in the human internal mammary artery Cardiovasc. Res. 65 2005 913 920
11. M.L. Cohen, W. Bloomquist, D. Li, and S. Iyengar Effect of acute and subchronic subcutaneous urocortin on blood pressure and food consumption in ob/ob mice Gen. Pharmacol. 34 2000 371 377
12. O.F. Cole, T.P. Fan, and G.P. Lewis Isolation, characterisation, growth and culture of endothelial cells from the rat aorta Cell. Biol. Int. Rep. 10 1986 399 405
13. O. Costerousse, J. Allegrini, J.P. Clozel, J. Menard, and F. Alhenc-Gelas Angiotensin I-converting enzyme inhibition but not angiotensin II suppression alters angiotensin I-converting enzyme gene expression in vessels and epithelia J. Pharmacol. Exp. Ther. 284 1998 1180 1187
14. D.W. Cushman, and M.A. Ondetti Inhibitors of angiotensin-converting enzyme Prog. Med. Chem. 17 1980 41 104
15. C.J. Donaldson, S.W. Sutton, M.H. Perrin, A.Z. Corrigan, K.A. Lewis, J.E. Rivier, J.M. Vaughan, and W.W. Vale Cloning and characterization of human urocortin Endocrinology 137 1996 2167 2170
16. F. Fyhrquist, T. Forslund, I. Tikkanen, and C. Gronhagen-Riska Induction of angiotensin I-converting enzyme rat lung with Captopril (SQ 14225) Eur. J. Pharmacol. 67 1980 473 475
17. F. Fyhrquist, C. Gronhagen-Riska, T. Forslund, and I. Tikkanen Induction of angiotensin I-converting enzyme in rat lung with captopril: the effect of adrenalectomy Am. J. Cardiol. 49 1982 1508 1510
18. P.E. Gallagher, P. Li, J.R. Lenhart, M.C. Chappell, and K.B. Brosnihan Estrogen regulation of angiotensin-converting enzyme mRNA Hypertension 33 1999 323 328
19. A.L. Garcia-Villalon, E. Sanz, L. Monge, N. Fernandez, B. Climent, and G. Dieguez Urocortin protects coronary endothelial function during ischemia-reperfusion: a brief communication Exp. Biol. Med. 229 2004 118 120
20. G.H. Gibbons The pathophysiology of hypertension: the importance of angiotensin II in cardiovascular remodeling Am. J. Hypertens. 11 1998 177S 181S
21. J.L. Groff, J.B. Harp, and M. DiGirolamo Simplified enzymatic assay of angiotensin-converting enzyme in serum Clin. Chem. 39 1993 400 404
22. + channels in endothelium independent relaxation by urocortin in the rat coronary artery Cardiovasc. Res. 57 2003 824 833
23. + channels Br. J. Pharmacol. 135 2002 1467 1476
24. Y. Huang, X.Q. Yao, C.W. Lau, Y.C. Chan, S.Y. Tsang, and F.L. Chan Urocortin and cardiovascular protection Acta Pharm. Sin. 25 2004 257 265
25. V. Jain, M. Longo, M. Ali, G.R. Saade, K. Chwalisz, and R.E. Garfield Expression of receptors for corticotropin-releasing factor in the vasculature of pregnant rats J. Soc. Gynecol. Investig. 7 2000 153 160
26. A. Jankowski, A. Skorek, K. Krzysko, P.K. Zarzycki, R.J. Ochocka, and H. Lamparczyk Captopril: determination in blood and pharmacokinetics after single oral dose J. Pharm. Biomed. Anal. 13 1995 655 660
27. E. Jaspard, O. Costerousse, L. Wei, P. Corvol, and F. Alhenc-Gelas The angiotensin I-converting enzyme (kinase II): molecular and regulatory aspects Agents Actions Suppl. 38 1992 349 358
28. K. Kageyama, K. Furukawa, I. Miki, K. Terui, S. Motomura, and T. Suda Vasodilative effects of urocortin II via protein kinase A and a mitogen-activated protein kinase in rat thoracic aorta J. Cardiovasc. Pharmacol. 42 2003 561 565
29. K. Kohlstedt, R.P. Brandes, W. Muller-Esterl, R. Busse, and I. Fleming Angiotensin converting enzyme is involved in outside-in signaling in endothelial cells Circ. Res. 94 2004 60 67
30. T. Kokubu, E. Ueda, M. Ono, T. Kawabe, Y. Hayashi, and T. Kan Effects of captopril (SQ 14, 225) on the renin-angiotensin-aldosterone system in normal rats Eur. J. Pharmacol. 62 1980 269 275
31. F.M. Lai, T. Tanikella, H. Herzlinger, and P. Cervoni Effect of the time interval between blood sampling and assay on serum angiotensin I-converting enzyme activity from captopril-treated rats Eur. J. Pharmacol. 67 1980 97 99
32. C.W. Lau, Y.C. Chan, X. Yao, F.L. Chan, Z.Y. Chen, and Y. Huang Nickel inhibits urocortin-induced relaxation in the rat pulmonary artery Eur. J. Pharmacol. 488 2004 169 172
33. C.N. Liu, C. Yang, X. Liu, and S. Li In vivo protective effects of urocortin on ischemia/reperfusion injury in rat heart via free radical mechanisms Can. J. Physiol. Pharm. 83 6 2005 459 465
34. J.C. Magee, A.E. Stone, K.T. Oldham, and K.S. Guice Isolation, culture, and characterization of rat lung microvascular endothelial cells Am. J. Physiol. 267 1994 L433 L441
35. I. Miki, K. Seya, S. Motomura, and K. Furukawa Role of corticotropin releasing factor receptor type 2 beta in urocortin-induced vasodilation of rat aortas J. Pharm. Sci. 96 2004 170 176
36. J.M. Neutel Effect of the renin-angiotensin system on the vessel wall: using ACE inhibition to improve endothelial function J. Hum. Hypertens. 18 2004 599 606
37. A. Okosi, B.K. Brar, M. Chan, L. D'Souza, E. Smith, A. Stephanou, D.S. Latchman, H.S. Chowdrey, and R.A. Knight Expression and protective effects of urocortin in cardiac myocytes Neuropeptides 32 1998 167 171
38. S. Oparil, and E. Haber The renin-angiotensin system N. Engl. J. Med. 291 1974 446 457
39. D.G. Parkes, and C.N. May Urocortin: a novel player in cardiac control News Physiol. Sci. 15 2000 264 268
40. M.T. Rademaker, C.J. Charles, E.A. Espiner, S. Fisher, C.M. Frampton, C.M. Kirkpatrick, J.G. Lainchbury, M.G. Nicholls, A.M. Richards, and W.W. Vale Beneficial hemodynamic, endocrine, and renal effects of urocortin in experimental heart failure: comparison with normal sheep J. Am. Coll. Cardiol. 40 2002 1495 1505
41. M.T. Rademaker, C.J. Charles, E.A. Espiner, C.M. Frampton, J.G. Lainchbury, and A.M. Richards Endogenous urocortins reduce vascular tone and renin-aldosterone/endothelin activity in experimental heart failure Eur. Heart J. 26 19 2005 2046 2054
42. L. Schilling, C. Kanzler, P. Schmiedek, and H. Ehrenreich Characterization of the relaxant action of urocortin, a new peptide related to corticotropin-releasing factor in the rat isolated basilar artery Br. J. Pharmacol. 125 1998 1164 1171
43. A.W. Scribner, J. Loscalzo, and C. Napoli The effect of angiotensin-converting enzyme inhibition on endothelial function and oxidant stress Eur. J. Pharmacol. 482 2003 95 99
44. A.M. Sharifi, N. Akbarloo, R. Darabi, and B. Larijani Study of correlation between elevation of blood pressure and tissue ACE activity during development of hypertension in 1K1C rats Vasc. Pharmacol. 41 2004 15 20
45. J. Tao, H. Xu, C. Yang, C.N. Liu, and S. Li Effect of urocortin on L-type calcium currents in adult rat ventricular myocytes Pharmacol. Res. 50 2004 471 476
46. J. Vaughan, C. Donaldson, J. Bittencourt, M.H. Perrin, K. Lewis, and S. Sutton Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor Nature 378 1995 287 292
47. R.S. Weisinger, J.R. Blair-West, P. Burns, D.A. Denton, B. Purcell, W. Vale, J. Rivier, H.S. Weisinger, and C.N. May Cardiovascular effects of long-term central and peripheral administration of urocortin, corticotropin-releasing factor, and adrenocorticotropin in sheep Endocrinology 145 2004 5598 5604